Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MTHFD2 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → MTHFD2 |
| (<<) ASNS → MTHFD2 |
| (<<) CCNB1 → MTHFD2 |
| (<<) MAFF → MTHFD2 |
| (<<) ORC6L → MTHFD2 |
| (<<) RXRA → MTHFD2 |
| (<<) TUBA1B → MTHFD2 |
| Downstream (Children) |
|---|
| MTHFD2 → ATF4 (>>) |
| MTHFD2 → ATP2B1 (>>) |
| MTHFD2 → CASP5 (>>) |
| MTHFD2 → CCNB2 (>>) |
| MTHFD2 → CD3EAP (>>) |
| MTHFD2 → CDH3 (>>) |
| MTHFD2 → CHAC1 (>>) |
| MTHFD2 → DDX21 (>>) |
| MTHFD2 → DLAT (>>) |
| MTHFD2 → EIF2C2 (>>) |
| MTHFD2 → FERMT1 (>>) |
| MTHFD2 → FZD6 (>>) |
| MTHFD2 → GSTK1 (>>) |
| MTHFD2 → HDAC6 (>>) |
| MTHFD2 → HK2 (>>) |
| MTHFD2 → HLA-DOA (>>) |
| MTHFD2 → HSP90AA1 (>>) |
| MTHFD2 → LRP8 (>>) |
| MTHFD2 → MEF2D (>>) |
| MTHFD2 → MMP12 (>>) |
| MTHFD2 → MPP1 (>>) |
| MTHFD2 → ODC1 (>>) |
| MTHFD2 → PDK2 (>>) |
| MTHFD2 → PFDN2 (>>) |
| MTHFD2 → PHLDA2 (>>) |
| MTHFD2 → PKM2 (>>) |
| MTHFD2 → PLK1 (>>) |
| MTHFD2 → PSAT1 (>>) |
| MTHFD2 → PTPLA (>>) |
| MTHFD2 → S100P (>>) |
| MTHFD2 → SLC7A5 (>>) |
| MTHFD2 → TARS (>>) |
| MTHFD2 → TK1 (>>) |
| MTHFD2 → UBE2N (>>) |
| MTHFD2 → VAV3 (>>) |
